Check out key resources in the new Lexis Practice Advisor® Life Sciences practice area

Check out key resources in the new Lexis Practice Advisor® Life Sciences practice area

Released in August, the Life Sciences practice area includes practical guidance documents to help legal professionals efficiently and effectively represent drug, medical device and biotechnology companies in transactional and regulatory compliance matters ranging from Research and Development and Clinical Trials to Patents and Licensing, Regulatory Enforcement and Corporate Transactions (U.S. and International). Highlights include: four regulatory trackers (FDA Warning Letters Tracker, Drug and Medical Device OIG Advisory Opinions Tracker, FDA Drug Regulatory Activity Tracker and FDA Medical Device Regulatory Activity Tracker); practice notes and checklists drafted by leading authors such as Regulatory Due Diligence for Medical Device Technology Transactions and Data Integrity Risk Management for Life Sciences Checklist; and drafting resources and forms such as Clinical Research Support Agreement and Master Clinical Trial Agreement.

The practice area also features curated, targeted life sciences drafting precedents through Transactions Search powered by Intelligize® on topics including research and development agreements and clinical trial agreements.